Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:healthcare_organization
|
| gptkbp:affiliatedWith |
gptkb:University_of_Tennessee_College_of_Medicine
|
| gptkbp:collaboratesWith |
Research institutions
Pharmaceutical companies |
| gptkbp:hasAccreditation |
gptkb:American_College_of_Surgeons_Commission_on_Cancer
gptkb:American_College_of_Radiology gptkb:National_Accreditation_Program_for_Breast_Centers |
| gptkbp:hasCapacity |
Outpatient services
Inpatient_beds |
| gptkbp:hasOccupation |
Support groups
Awareness campaigns Educational seminars Partnerships with local organizations Screening programs |
| gptkbp:hasResearchFocus |
Cancer prevention
Patient outcomes Genetic research Cancer treatment innovations |
| gptkbp:hasSpecialty |
gptkb:Lung_cancer
Breast cancer Colorectal cancer Prostate cancer Skin cancer Hematologic malignancies Neuro-oncology Gynecologic cancers Head and neck cancers |
| gptkbp:hasTechnology |
gptkb:Robotic_surgery_systems
Electronic health records Advanced imaging technology Radiation therapy equipment Chemotherapy_administration_systems |
| https://www.w3.org/2000/01/rdf-schema#label |
Erlanger Cancer Institute
|
| gptkbp:locatedIn |
gptkb:Chattanooga,_Tennessee
|
| gptkbp:offers |
gptkb:Chemotherapy
Radiation therapy Surgical oncology |
| gptkbp:provides |
Clinical trials
Palliative care Support services Nutritional counseling Psychosocial support |
| gptkbp:providesSupportFor |
Phase III trials
Phase I trials Phase II trials Immunotherapy trials Targeted therapy trials |